RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia
SNAUWAERT, Sylvia, VANHEE, Stijn, LECIERCQ, Georges, THIELEMANS, Kris, KERRE, Tessa, VANDEKERCKHOVE, Bart, GOETGELUK, Glenn, VERSTICHEL, Greet, VAN CAENEGHEM, Yasmine, VELGHE, Imke, PHILIPPE, Jan, BERNEMAN, Zwi N, PLUM, Jean, TAGHON, Tom
Published in Haematologica (Roma) (01.10.2012)
Published in Haematologica (Roma) (01.10.2012)
Get full text
Journal Article